Device recall · January 22, 2025
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 recall
Why: The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361
- Lots / codes
UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1
- Quantity
- 10 units
- Company
- DRG International, Inc., Springfield, NJ
- Distribution
- Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
- Initiated
- October 7, 2024 · Voluntary: Firm initiated
- Classified
- January 15, 2025
- Reported
- January 22, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.